Search

Displaying results 4291 - 4300 of 6951 in total
  1. Drug

    Osanetant

    go.drugbank.com/drugs/DB04872
    Investigational

    Developed by Sanofi-Aventis (formerly Sanofi-Synthelabo), osanetant (SR-142801) is an NK3 receptor antagonist which was under development for the treatment of schizophrenia and other Central Nervous System … This follows an earlier decision to discontinue development of eplivanserin for schizophrenia.

  2. Drug

    EMZ702

    go.drugbank.com/drugs/DB05021
    Investigational

    EMZ702, a non-toxic agent that has strong anti-viral synergy with interferon, is an ideal candidate for combination with current standard hepatitis C treatments. … EMZ702 has an excellent safety profile and the combination of EMZ702 with interferon and ribavirin in surrogate models for hepatitis C has demonstrated a two to three fold increase in anti-viral potency

  3. Drug

    Dimethyl sulfone

    go.drugbank.com/drugs/DB14090
    Investigational

    Mixtures: Conart-MSM Sachet for Oral Solution, Condrosa-MSM Sachet for Oral Solution
  4. Drug

    Nesbuvir

    go.drugbank.com/drugs/DB07238
    Investigational

    Nesbuvir has been investigated for the treatment of Hepatitis C.

  5. Drug

    Emodin

    go.drugbank.com/drugs/DB07715
    Investigational

    Emodin has been investigated for the treatment of Polycystic Kidney.

  6. Drug

    Bapineuzumab

    go.drugbank.com/drugs/DB11715
    Investigational

    Bapineuzumab has been investigated for the treatment of Alzheimer's Disease.

  7. Drug

    Pefcalcitol

    go.drugbank.com/drugs/DB11786
    Investigational

    Pefcalcitol has been investigated for the basic science of Psoriasis.

  8. Drug

    Doxifluridine

    go.drugbank.com/drugs/DB12947
    Investigational

    Doxifluridine has been investigated for the treatment of Stomach Cancer.

  9. Drug

    Saroglitazar

    go.drugbank.com/drugs/DB13115
    Investigational

    Saroglitazar has been investigated for the treatment of Fatty Liver.

  10. Drug

    Epelsiban

    go.drugbank.com/drugs/DB11934
    Investigational

    Epelsiban has been investigated for the treatment of Premature Ejaculation.